Study Group: Breast Oncologists (US)
Council Members in this Study Group: 313
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Taral PatelOncologist
MID-OHIO ONCOLOGY & HEMOTOLOGY INC
Taral Patel, MD, is an Oncologist in private practice with Mid Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been a principal investigator for multiple clinical trials in colon cancer, lung cancer,...
- Michael Grossbard
Professor of Clinical Medicine
Columbia University College of Physicians and SurgeonsMichael Grossbard, MD, is a Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and the Chief of Hematology-Oncology at St. Luke's-Roosevelt Hospital and Beth Israel Medical Center in New York City. His clinical research...
- Sujith Kalmadi
Staff Physician
Ironwood Cancer & Research CenterSujith Kalmadi, MD, is a Staff Physician at the Ironwood Cancer and Research Center in Phoenix, Arizona. Dr. Kalmadi has previously worked as a Clinical Assistant Professor at Baylor school of Medicine in Houston, Texas, and at the Lerner School of Medicine...
Haitham Al-OkkAssistant Clinical Professor - Hematology-Oncology
Mahr Cancer CenterHaitham Al-Okk, MD, is a Specialist in Hematology-Oncology at Graves-Gilbert Cancer Clinic, a multi-specialty medical group in Kentucky. Dr. Al-Okk is board certified in Internal Medicine and Medical Oncology, and fellowship trained in Hematology-Oncology....
- Kapil Bhalla
Director of Cancer Center
MEDICAL COLLEGE OF GEORGIAKapil Bhalla, MD, is the Director of Cancer Center and a Professor of Medicien in the Department of Hematology-Oncology at Medical College of Georgia. Dr. Bhalla’s research interests include molecular regulation of apoptosis induced by anti-leukemic nucleoside...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Avastin Raises Risk of Clots: New News?
December 1, 2008
Scientists recommend 'black box' for Avastin | www.fiercepharma.com
In pooled data from 8000 patients across 15 studies, the risk of blood clots was increased by 12% in patients receiving Avastin.
-
Amgen Rewords Label: Less Use of Procrit
August 29, 2008
Amgen Told to Reword Drug Label | www.nytimes.com
The FDA required Amgen to revise the label for Procrit and Aranesp so that these agents are not used until a patient's hemoglobin drops below 10 or in the setting of potentially curative therapy.
-
Transparency in Healthcare: How to Assess?
August 29, 2008
Transparency in Healthcare | www.hospitalimpact.org
The author argues that transparency in healthcare will be an important step forward for the consumer.
-
August 29, 2008
Costly Cancer Drug Offers Hope, but Also a Dilemma | www.nytimes.com
Avastin improves survival in colon cancer and lung cancer and improves progression free survival in breast cancer- clinically meaningful outcomes. Yet these gains are of relatively short duration and the cost of Avastin is significant- 50,000 to 100,000 dollars per year.
-
NICE States Novel Therapies for Renal Cell Cancer Too Costly
August 28, 2008
UK Says Kidney Cancer Drugs Are Too Pricey | www.pharmalot.com
NICE has stated that the cost of several novel agents for the treatment of renal cell cancer including Sutent, Torisel, Avastin, and Nexavar exceeds the benefit when assessed by quality adjusted life years (QALY) gained from the therapies.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Partner
- Owner
- Physician - Division Head